A biotechnology company aims to produce a monoclonal antibody that can specifically detect a toxin produced by a pathogenic bacterium in contaminated food samples.
Explain how the hybridoma method can be used to generate this monoclonal antibody and how the structure of an antibody enables its use in such diagnostic tests.